Helesbeux, J.-J.; Carro, L.; McCarthy, F.O.; Moreira, V.M.; Giuntini, F.; O’Boyle, N.; Matthews, S.E.; Bayraktar, G.; Bertrand, S.; Rochais, C.;
et al. 29th Annual GP2A Medicinal Chemistry Conference. Pharmaceuticals 2021, 14, 1278.
https://doi.org/10.3390/ph14121278
AMA Style
Helesbeux J-J, Carro L, McCarthy FO, Moreira VM, Giuntini F, O’Boyle N, Matthews SE, Bayraktar G, Bertrand S, Rochais C,
et al. 29th Annual GP2A Medicinal Chemistry Conference. Pharmaceuticals. 2021; 14(12):1278.
https://doi.org/10.3390/ph14121278
Chicago/Turabian Style
Helesbeux, Jean-Jacques, Laura Carro, Florence O. McCarthy, Vânia M. Moreira, Francesca Giuntini, Niamh O’Boyle, Susan E. Matthews, Gülşah Bayraktar, Samuel Bertrand, Christophe Rochais,
and et al. 2021. "29th Annual GP2A Medicinal Chemistry Conference" Pharmaceuticals 14, no. 12: 1278.
https://doi.org/10.3390/ph14121278
APA Style
Helesbeux, J.-J., Carro, L., McCarthy, F. O., Moreira, V. M., Giuntini, F., O’Boyle, N., Matthews, S. E., Bayraktar, G., Bertrand, S., Rochais, C., & Marchand, P.
(2021). 29th Annual GP2A Medicinal Chemistry Conference. Pharmaceuticals, 14(12), 1278.
https://doi.org/10.3390/ph14121278
